Use of ibandronate for promoting osseointegration of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/663 (2006.01) A61K 31/66 (2006.01) A61P 19/00 (2006.01)

Patent

CA 2353528

The invention relates to use of ibandronic acid (1-hydroxy-3-(N-methyl-N- pentyl)aminopropyl-1,1-diphosphonic acid) or physiologically compatible salts or esters thereof for improving the osseointegration of cement-free anchored endoprostheses. Ibandronate or salts thereof is applied for a short time immediately after insertion of an endoprosthesis, with the surprising result that secondary stability of the implant is obtained in only 5 weeks or less after the operation.

L'invention concerne l'utilisation d'acide ibandronique (1-hydroxy-3-(N-méthyl-N-pentyl)aminopropyl-1,1-acide diphosphonique) ou de sels ou d'esters physiologiquement compatibles pour améliorer l'osséointégration d'endoprothèses ancrées sans ciment. Le procédé selon l'invention consiste à appliquer de l'ibandronate ou des sels de ce dernier pendant un laps de temps court après l'insertion d'une endoprothèse, ce qui permet, de manière surprenante, d'obtenir une stabilité secondaire de l'implant seulement cinq semaines ou moins après l'opération.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of ibandronate for promoting osseointegration of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of ibandronate for promoting osseointegration of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of ibandronate for promoting osseointegration of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1766369

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.